These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 11779443

  • 1. Effect of ipratropium bromide on airway and pulmonary muscarinic receptors in a rat model of chronic obstructive pulmonary disease.
    Yao W, Wang G, Zhu H, Sun Y, Zhao M.
    Chin Med J (Engl); 2001 Jan; 114(1):80-3. PubMed ID: 11779443
    [Abstract] [Full Text] [Related]

  • 2. [The effect of inhaled ipratropium bromide on airway and lung tissue muscarinic receptors in a rat model of COPD].
    Yao W, Wang G, Zhu H, Zhao M.
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):95-7. PubMed ID: 11820950
    [Abstract] [Full Text] [Related]

  • 3. [Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors].
    Abad Santos F, Novalbos J, Gallego Sandín S, Gálvez Múgica MA.
    An Med Interna; 2003 Apr; 20(4):201-5. PubMed ID: 12768836
    [Abstract] [Full Text] [Related]

  • 4. [Effects of salbutamol and ipratropium bromide on arterial blood gases in patients with stable COPD].
    Ozdemir T, Geçkin E, Oğüş C, Cilli A.
    Tuberk Toraks; 2003 Apr; 51(2):132-7. PubMed ID: 15143418
    [Abstract] [Full Text] [Related]

  • 5. [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)].
    Beeh KM, Welte T, Buhl R.
    Pneumologie; 2003 Sep; 57(9):519-25. PubMed ID: 13680472
    [Abstract] [Full Text] [Related]

  • 6. Comparative characterization of lung muscarinic receptor binding after intratracheal administration of tiotropium, ipratropium, and glycopyrrolate.
    Ogoda M, Niiya R, Koshika T, Yamada S.
    J Pharmacol Sci; 2011 Sep; 115(3):374-82. PubMed ID: 21358117
    [Abstract] [Full Text] [Related]

  • 7. [The effects of recombinant human tumor necrosis factor-Fc on pulmonary function in a rat model of chronic obstructive pulmonary disease].
    Zhang C, Chen P, Cai S, Chen JB, Wu J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):432-6. PubMed ID: 17673016
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Muscarinic cholinergic receptor antagonists enhanced the expression of CD(8)(+)CD(25)(+)Foxp(3)(+) regulatory T cells in stable COPD patients].
    Zhang JC, Wang P, Xiong XZ, Deng L, Xin JB, Ma WL, Shi HZ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jan; 33(1):33-6. PubMed ID: 20368022
    [Abstract] [Full Text] [Related]

  • 10. [A study on pathological changes and the potential role of growth factors in the airway wall remodeling of COPD rat models].
    Song Y, Cui D, Mao P.
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 May; 24(5):283-7. PubMed ID: 11802977
    [Abstract] [Full Text] [Related]

  • 11. Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease.
    Barnes PJ, Belvisi MG, Mak JC, Haddad EB, O'Connor B.
    Life Sci; 1995 May; 56(11-12):853-9. PubMed ID: 10188785
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
    Beeh KM, Beier J, Buhl R, Stark-Lorenzen P, Gerken F, Metzdorf N, ATEM-Studiengruppe.
    Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D.
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [Abstract] [Full Text] [Related]

  • 14. Establishment and pathological study of models of chronic obstructive pulmonary disease by SO2 inhalation method.
    Xu J, Zhao M, Liao S.
    Chin Med J (Engl); 2000 Mar; 113(3):213-6. PubMed ID: 11775248
    [Abstract] [Full Text] [Related]

  • 15. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.
    Gavaldà A, Miralpeix M, Ramos I, Otal R, Carreño C, Viñals M, Doménech T, Carcasona C, Reyes B, Vilella D, Gras J, Cortijo J, Morcillo E, Llenas J, Ryder H, Beleta J.
    J Pharmacol Exp Ther; 2009 Nov; 331(2):740-51. PubMed ID: 19710368
    [Abstract] [Full Text] [Related]

  • 16. [Tiotropium bromide for treating chronic obstructive pulmonary disease].
    Uteshev DB, Buniatian ND, Kovaleva VL.
    Eksp Klin Farmakol; 2010 Nov; 73(11):15-8. PubMed ID: 21254592
    [Abstract] [Full Text] [Related]

  • 17. [Lung function and exercise tolerance after treatment with salmeterol or ipratropium bromide in chronic obstructive pulmonary disease].
    Grzanka A, Pitsch T, Krzywiecki A, Rogala B.
    Pol Merkur Lekarski; 2004 Sep; 17(99):208-11. PubMed ID: 15628041
    [Abstract] [Full Text] [Related]

  • 18. [The changes of apoptosis and proliferation of pulmonary tissue in chronic obstructive pulmonary disease rats].
    Cao GQ, Qian GS, Lin L, Cui SH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Mar; 28(3):169-72. PubMed ID: 15854411
    [Abstract] [Full Text] [Related]

  • 19. An update on the efficacy and safety of aclidinium bromide in patients with COPD.
    Alagha K, Bourdin A, Tummino C, Chanez P.
    Ther Adv Respir Dis; 2011 Feb; 5(1):19-28. PubMed ID: 20884687
    [Abstract] [Full Text] [Related]

  • 20. Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping.
    Haddad EB, Mak JC, Barnes PJ.
    Mol Pharmacol; 1994 May; 45(5):899-907. PubMed ID: 8190106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.